Osaka Soda to expand pharmaceutical silica gel production facilities at Matsuyama plant
Construction starts in about 1 months; completion is scheduled about 17 months from now.
Osaka Soda held a groundbreaking ceremony for an expansion of pharmaceutical purification silica gel production facilities at its Matsuyama plant in Matsuyama, Ehime. The project is part of a plan investing more than JPY 10 billion across the Matsuyama and Amagasaki plants to roughly double combined production capacity, driven by growing demand from diabetes and obesity drug manufacturers.
Project facts
- Owner
- Osaka Soda Co., Ltd.
- Listing
- 4046 Tokyo
- Facility
- Factory/Plant
- Sector
- Materials & chemicals
- Location
- Matsuyama, Ehime, Japan
- Investment
- ¥10B — total for the Matsuyama and Amagasaki plants; more than JPY 10 billion
- Scale / capacity
- approximately twice the current combined production capacity of the Matsuyama and Amagasaki plants
- Construction start
- Oct 20, 2026
- Completion
- Feb 28, 2028
- Announced
- Oct 8, 2026
- Themes
- semiconductor-supply-chain
Figures and schedules are as announced by the company or the public body concerned; plans can change. Amounts that were not disclosed are recorded as not disclosed, never estimated.